Collectively, these results provide evidence that HNSCC cells, regardless of their p53 status, do maintain redox capabilities; yet, cells with a mutation of TP53 seem to have acquired the ability to reduce ROS to a level that will diminish the amount of permanent cell damage. Here, TP53 is linked to head and neck squamous cell carcinoma.